Cite
APA Citation
Tanaka, T., Kitamura, H., Inoue, R., Nishida, S., Takahashi-Takaya, A., Kawami, S., Torigoe, T., Hirohashi, Y., Tsukamoto, T., Sato, N., & Masumori, N. (2013). potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials. Clinical & developmental immunology, 2013, . http://access.bl.uk/ark:/81055/vdc_100130167440.0x00003b